Fouad Jabbour, MD
Interventional Cardiology · Greensburg, PANPI 1205368883
Payments from drug & device makers
Across 139 payments — averaging $67.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Edwards Lifesciences$1K
- Abiomed$1K
- Abbott$813
- W. L. Gore & Associates, Inc.$597
- Medtronic$514
- plus $3K from 19 others
What the payments were for
- Grants$1,06311%
- Travel & lodging$5886%
- Food & beverage$7,55880%
- Education$2092%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 26 | $2,165 |
| Edwards Lifesciences | 14 | $1,147 |
| Abiomed | 19 | $1,040 |
| Abbott | 17 | $813 |
| W. L. Gore & Associates, Inc. | 6 | $597 |
| Medtronic | 5 | $514 |
| Heartflow, Inc. | 8 | $430 |
| Teleflex LLC | 3 | $407 |
| Amgen | 8 | $386 |
| Shockwave Medical, Inc | 4 | $301 |
| Boehringer Ingelheim | 5 | $290 |
| AstraZeneca | 3 | $245 |
| Inari Medical, Inc. | 2 | $183 |
| Cardiovascular Systems Inc. | 1 | $134 |
| Penumbra, Inc. | 2 | $111 |
| E.r. Squibb & Sons, L.L.C. | 1 | $107 |
| Cordis US CORP. | 1 | $102 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $96 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $82 |
| Johnson & Johnson | 5 | $79 |
| Chiesi USA, Inc. | 1 | $72 |
| Terumo Medical Corporation | 3 | $67 |
| Novo Nordisk | 1 | $20 |
| Novartis | 1 | $17 |
| Cardiva Medical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GORE CARDIOFORM Septal Occluder$571
- Impella$524
- COREVALVE EVOLUT R$461
- AVVIGO Guidance System$390
- Edwards SAPIEN 3 Transcatheter Heart Valve$335
- Diamondback Coronary$277
- GUIDELINER$269
- Repatha$227
- JARDIANCE$226
- EnSite Precision Cardiac Mapping System$208
- FLOWTRIEVER CATHETER, S$202
- WATCHMAN FLX$166
- COROFLOW$153
- OPTICROSS$148
- FFRct$147
- SPECTRE$138
- BRILINTA$125
- FARXIGA$106
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$104
- MYNX CONTROL$102
How this compares
$9,418 in reported general payments places this provider in the 50th percentile of 281 interventional cardiology providers in Pennsylvania.
See all interventional cardiology providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 13 | $270 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Greensburg
- William GrayWynnewood$3.3M
- Eric GnallWynnewood$2.4M
- Howard HerrmannPhiladelphia$2.2M
- Ramzi KhalilPittsburgh$1.6M
- Nishant SethiScranton$1.3M
- Matthew BeckerErie$1.3M
- David LasordaPittsburgh$1.1M
- Nainesh PatelAllentown$1.1M
- Jay GiriPhiladelphia$1M
- James HarveyChambersburg$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.